The enzyme-linked immunosorbent assay testing global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Enzyme-Linked Immunosorbent Assay Testing Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The enzyme-linked immunosorbent assay testing market size has grown strongly in recent years. It will grow from $2.68 billion in 2023 to $2.85 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to the prevalence of chronic diseases, increased funding and emphasis on biomedical research, approval of ELISA tests by regulatory bodies, government initiatives, and health awareness programs.
The enzyme-linked immunosorbent assay testing market size is expected to see strong growth in the next few years. It will grow to $3.65 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to rising demand for personalized medicine, a growing geriatric population, greater emphasis on early detection, improved access to healthcare services, and a and a growing need for chronic disease monitoring. Major trends in the forecast period include technological advancements, growing demand for point-of-care testing, expanding application areas, the adoption of high-throughput screening, and the emergence of digital ELISA.
Order your report now for swift delivery @
Scope Of Enzyme-Linked Immunosorbent Assay Testing Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Enzyme-Linked Immunosorbent Assay Testing Market Overview
Market Drivers –
The growing incidence of infectious disorders is expected to propel the growth of the enzyme-linked immunosorbent assay testing market going forward. Infectious disorders are diseases caused by pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites, which can spread between individuals and impact various body systems. The growing incidence of infectious disorders can be attributed to increased global travel and the rise of antimicrobial resistance, which complicates infection control. Enzyme-linked immunosorbent assay (ELISA) testing is helpful for infectious disorders as it allows for the accurate detection and quantification of specific antigens or antibodies related to the infection, aiding in diagnosis, monitoring disease progression, and evaluating treatment effectiveness. For instance, in February 2024, according to data published by the World Health Organization, a Switzerland-based intergovernmental public health organization, a total of 58114 measles (a highly contagious viral disease) cases were reported in the European Region in 2023, compared to 941 cases in 2022. Therefore, the growing incidence of infectious disorders is driving the growth of the enzyme-linked immunosorbent assay testing market.
Market Trends –
Major companies in the enzyme-linked immunosorbent assay testing market are focusing on broadening their offerings through product innovations, such as novel enzyme-linked immunosorbent assay (ELISA) kits, to enhance diagnostic accuracy and meet diverse research and clinical needs. Novel Enzyme-Linked Immunosorbent Assay (ELISA) kits refer to advanced versions of ELISA tests that offer improved accuracy, sensitivity, and usability for detecting and quantifying biomarkers. For instance, in February 2023, Charles River Laboratories, a US-based pharmaceutical company, introduced a novel enzyme-linked immunosorbent assay (ELISA) kit for the detection and quantitation of residual host cell proteins (HCP) in CHO-based biotherapeutics. This innovative kit utilizes avian immunoglobulin Y (IgY) antibodies sourced from specific pathogen-free (SPF) chicken eggs, providing enhanced sensitivity and specificity with detection limits as low as 0.1 ng/mL and 90% antibody coverage. This launch aims to improve quality control in biopharmaceutical development, ensuring the safety and efficacy of new therapies while allowing for flexible use by clients, either independently or with support from Charles River’s experts.
The enzyme-linked immunosorbent assay testing market covered in this report is segmented –
1) By Type: Direct Enzyme-Linked Immunosorbent Assay (ELISA), Sandwich Enzyme-Linked Immunosorbent Assay (ELISA), Indirect Enzyme-Linked Immunosorbent Assay (ELISA), Multiple And Portable Enzyme-Linked Immunosorbent Assay (ELISA), Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
2) By Application: Immunology, Inflammation, Infectious Diseases, Cancer, Protein Quantitation, Other Applications
3) By End-User: Hospitals And Diagnostic Centers, Research Laboratories, Other End-Users
Get an inside scoop of the enzyme-linked immunosorbent assay testing market, Request now for Sample Report @
Regional Insights –
North America was the largest region in the enzyme-linked immunosorbent assay testing market in 2023. The regions covered in the enzyme-linked immunosorbent assay testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the enzyme-linked immunosorbent assay testing market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Tecan Group Ltd., GenScript Biotech Corporation, Promega Corporation, Abcam plc, R&D Systems Inc., Sino Biological Inc., OriGene Technologies Inc., RayBiotech Inc., Santa Cruz Biotechnology Inc., AnaSpec Inc., Biomatik, Arigo Biolaboratories Corp., MyBioSource Inc., Boster Biological Technology, Eagle Biosciences Inc., Enzo Life Sciences Inc., StressMarq Biosciences Inc., XpressBio
Table of Contents
1. Executive Summary
2. Enzyme-Linked Immunosorbent Assay Testing Market Report Structure
3. Enzyme-Linked Immunosorbent Assay Testing Market Trends And Strategies
4. Enzyme-Linked Immunosorbent Assay Testing Market – Macro Economic Scenario
5. Enzyme-Linked Immunosorbent Assay Testing Market Size And Growth
…..
27. Enzyme-Linked Immunosorbent Assay Testing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
Twitter: https://twitter.com/tbrc_info
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
